Abstract
Background: Plasma homocysteine is an independent non-traditional risk factor for atherosclerotic cardiovascular disease. The impact of statin therapy on plasma homocysteine is not conclusive.
Objective: To evaluate the effect of statin therapy on plasma homocysteine concentrations in a systematic review and meta-analysis of controlled clinical trials.
The secondary aim was to assess the comparative effect of statins versus fibrates on plasma homocysteine levels in head-to-head trials.
Method: PubMed-Medline, SCOPUS, Web of Science and Google Scholar databases were searched (from the first reports to March 07, 2016) to identify controlled trials evaluating the impact of statins on plasma homocysteine concentrations. A systematic assessment of bias in the included studies was performed using the Cochrane criteria. A random-effects model and generic inverse variance method were used for quantitative data synthesis. Sensitivity analysis was conducted using the leave-one-out method. Random-effects meta-regression was performed using unrestricted maximum likelihood method to evaluate the impact of potential moderators.
Results: Meta-analysis of data from 7 studies did not suggest a significant alteration in plasma homocysteine concentrations following treatment with statins compared with the control group (WMD: -0.59 μmol/L, 95% CI: -1.66, 0.48, p=0.279; I2=52.53%). However, meta-analysis of 9 studies suggested a significantly greater reduction of plasma homocysteine concentrations with statins compared with fenofibrate (WMD: -4.81 μmol/L, 95% CI: -5.39, -4.23, p<0.001; I2=0%). Results of both analyses were robust in the sensitivity analysis.
Conclusion: Statin therapy is not associated with a significant alteration of plasma homocysteine levels, while fenofibrate increases the homocysteine levels when compared with statins.
Keywords: Atherosclerosis, dyslipidemia, homocysteine, statins, fenofibrate, meta-analysis.
Current Medicinal Chemistry
Title:A Systematic Review and Meta-Analysis of Controlled Trials on the Effects of Statin and Fibrate Therapies on Plasma Homocysteine Levels
Volume: 23 Issue: 39
Author(s): Amirhossein Sahebkar, Matteo Pirro, Željko Reiner, Arrigo Cicero, Gianna Ferretti, Mario Simental-Mendía and Luis E. Simental-Mendía
Affiliation:
Keywords: Atherosclerosis, dyslipidemia, homocysteine, statins, fenofibrate, meta-analysis.
Abstract: Background: Plasma homocysteine is an independent non-traditional risk factor for atherosclerotic cardiovascular disease. The impact of statin therapy on plasma homocysteine is not conclusive.
Objective: To evaluate the effect of statin therapy on plasma homocysteine concentrations in a systematic review and meta-analysis of controlled clinical trials.
The secondary aim was to assess the comparative effect of statins versus fibrates on plasma homocysteine levels in head-to-head trials.
Method: PubMed-Medline, SCOPUS, Web of Science and Google Scholar databases were searched (from the first reports to March 07, 2016) to identify controlled trials evaluating the impact of statins on plasma homocysteine concentrations. A systematic assessment of bias in the included studies was performed using the Cochrane criteria. A random-effects model and generic inverse variance method were used for quantitative data synthesis. Sensitivity analysis was conducted using the leave-one-out method. Random-effects meta-regression was performed using unrestricted maximum likelihood method to evaluate the impact of potential moderators.
Results: Meta-analysis of data from 7 studies did not suggest a significant alteration in plasma homocysteine concentrations following treatment with statins compared with the control group (WMD: -0.59 μmol/L, 95% CI: -1.66, 0.48, p=0.279; I2=52.53%). However, meta-analysis of 9 studies suggested a significantly greater reduction of plasma homocysteine concentrations with statins compared with fenofibrate (WMD: -4.81 μmol/L, 95% CI: -5.39, -4.23, p<0.001; I2=0%). Results of both analyses were robust in the sensitivity analysis.
Conclusion: Statin therapy is not associated with a significant alteration of plasma homocysteine levels, while fenofibrate increases the homocysteine levels when compared with statins.
Export Options
About this article
Cite this article as:
Sahebkar Amirhossein, Pirro Matteo, Reiner Željko, Cicero Arrigo, Ferretti Gianna, Simental-Mendía Mario and Simental-Mendía E. Luis, A Systematic Review and Meta-Analysis of Controlled Trials on the Effects of Statin and Fibrate Therapies on Plasma Homocysteine Levels, Current Medicinal Chemistry 2016; 23 (39) . https://dx.doi.org/10.2174/0929867323666161007155310
DOI https://dx.doi.org/10.2174/0929867323666161007155310 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
Call for Papers in Thematic Issues
Advances in Medicinal Chemistry: From Cancer to Chronic Diseases.
The broad spectrum of the issue will provide a comprehensive overview of emerging trends, novel therapeutic interventions, and translational insights that impact modern medicine. The primary focus will be diseases of global concern, including cancer, chronic pain, metabolic disorders, and autoimmune conditions, providing a broad overview of the advancements in ...read more
Approaches to the treatment of chronic inflammation
Chronic inflammation is a hallmark of numerous diseases, significantly impacting global health. Although chronic inflammation is a hot topic, not much has been written about approaches to its treatment. This thematic issue aims to showcase the latest advancements in chronic inflammation treatment and foster discussion on future directions in this ...read more
Cellular and Molecular Mechanisms of Non-Infectious Inflammatory Diseases: Focus on Clinical Implications
The Special Issue covers the results of the studies on cellular and molecular mechanisms of non-infectious inflammatory diseases, in particular, autoimmune rheumatic diseases, atherosclerotic cardiovascular disease and other age-related disorders such as type II diabetes, cancer, neurodegenerative disorders, etc. Review and research articles as well as methodology papers that summarize ...read more
Chalcogen-modified nucleic acid analogues
Chalcogen-modified nucleosides, nucleotides and oligonucleotides have been of great interest to scientific research for many years. The replacement of oxygen in the nucleobase, sugar or phosphate backbone by chalcogen atoms (sulfur, selenium, tellurium) gives these biomolecules unique properties resulting from their altered physical and chemical properties. The continuing interest in ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
The Role of AMPK/mTOR Modulators in the Therapy of Acute Myeloid Leukemia
Current Medicinal Chemistry Vitamin D: Evolutionary, Physiological and Health Perspectives
Current Drug Targets Antidepressants: Update on Benefits and Risks
Current Psychopharmacology Value of Rox Index to Predict Intubation and Intensive Care Unit Outcome In Patients With Respiratory Failure
Reviews on Recent Clinical Trials Adenosine and Stroke: Maximizing the Therapeutic Potential of Adenosine as a Prophylactic and Acute Neuroprotectant
Current Neuropharmacology Peripartum Cardiomyopathy: Current State of Knowledge, New Developments and Future Directions
Current Cardiology Reviews Preface [Hot Topic: Treatment of Hypertension, Its Pathophysiology and the Clinical Use of Antihypertensive Drugs (Executive Editor: Gregory Y.H. Lip)]
Current Pharmaceutical Design Pro Atrial Natriuretic Peptide (1-30) and 6-keto PGF<sub>1α</sub> Activity Affects Na<sup>+</sup> Homeostasis in Non-modulating Hypertension
Current Hypertension Reviews Class IV Antiarrhythmic Agents: New Compounds Using an Old Strategy
Current Pharmaceutical Design Liposomes: Targeted and Controlled Delivery System
Drug Delivery Letters Social Media Use in Cardiovascular Imaging
Current Cardiology Reviews Effect of an Obesogenic Diet During the Juvenile Period on Growth Pattern, Fatness and Metabolic, Cardiovascular and Reproductive Features of Swine with Obesity/Leptin Resistance
Endocrine, Metabolic & Immune Disorders - Drug Targets Computer-Aided Drug Discovery (CADD) Approaches for the Management of Neuropathic Pain
Current Topics in Medicinal Chemistry Cellular Repressor of E1A-stimulated Genes, A New Potential Therapeutic Target for Atherosclerosis
Current Drug Targets Nuclear Membranes GPCRs: Implication in Cardiovascular Health and Diseases
Current Vascular Pharmacology Cell Cycle Re-Entry in Alzheimers Disease: A Major Neuropathological Characteristic?
Current Alzheimer Research Pleiotropic Effects of ARB in Vascular Metabolism - Focusing on Atherosclerosis-Based Cardiovascular Disease
Current Vascular Pharmacology Acute Myeloid Leukemia: Diagnosis and Management Based on Current Molecular Genetics Approach
Cardiovascular & Hematological Disorders-Drug Targets Synthesis and Antimicrobial Activity of Nitroalkenyl Arenes
Anti-Infective Agents Nuclear Imaging of Inflammation in Neurologic and Psychiatric Disorders
Current Clinical Pharmacology